DNA polymerase is an enzyme that synthesizes DNA molecules from deoxyribonucleotides, the building blocks of DNA. These enzymes are essential for DNA replication and usually work in pairs to create two identical DNA strands from a single original DNA molecule. During this process, DNA polymerase "reads" the existing DNA strands to create two new strands that match the existing ones. DNA polymerases are widely used for DNA manipulation in vitro, including DNA cloning, sequencing, labelling, mutagenesis, and other purposes. The fundamental ability of DNA polymerases to synthesize a deoxyribonucleotide chain is conserved. However, the more specific properties, including processivity, fidelity (synthesis accuracy), and substrate nucleotide selectivity, differ among the enzymes. The distinctive properties of each DNA polymerase may lead to the potential development of unique reagents, and therefore searching for novel DNA polymerase has been one of the major focuses in this research field. In addition, protein engineering techniques to create mutant or artificial DNA polymerases have been successfully developing powerful DNA polymerases, suitable for specific purposes among the many kinds of DNA manipulations. Thermostable DNA polymerases are especially important for PCR-related techniques in molecular biology.
Covid-19 Scenario analysis:
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future owing to the demand for vaccine and treatment drugs for COVID-19. This in turn is expected to have a significant impact on the DNA polymerase market.
Top impacting factors: Market Scenario Analysis, Trends, Drivers and Impact analysis:
Increase in number of chronic diseases:
There is a huge potential for the growth of the DNA polymerase market with the increasing incidence of cancer, neurological disorders, genetic mutation, and due to the increasing number of chronic diseases. According to WHO, the number of deaths due to cancer is expected to increase more than 70% over a decade. Also, increasing number of recombinant medicines for treating chronic diseases will drive the growth of the DNA polymerase market.
Extensive use in biotechnology field:
The market is growing at significant rate over the decade owing to increase in DNA polymerase usage in various industries such as forensic science, biopharmaceuticals, research centres, and diagnostic centres among others. DNA polymerase plays major role in various biotechnological techniques such as polymerase chain reaction (PCR), DNA cloning, DNA sequencing, single nucleotide polymorphism, whole genome amplification, and molecular diagnostics. Moreover, collaborations, launching of newer DNA polymerase enzymes, and patent approval are the key strategies followed by market players.
Apart from the factors increasing the growth of high-fidelity DNA polymerase market, there are few factors, which can hinder the overall growth of the high-fidelity DNA polymerase market. Lack of awareness in some of the research institutes, or lack of government funding in some of the developing regions, is expected to hinder the growth of high-fidelity DNA polymerase market.
North America dominates the DNA polymerase market in terms of geography due to extensive research carried out in this region and also due to well-structured healthcare facilities with advanced treatments. Europe is the second largest market for DNA polymerase due to wide-ranging research activities carried out in this region with all major companies owning high stakes in the region. Increasing mergers and acquisitions with medical technology being widely used has facilitated the growth of the DNA polymerase market. Asia Pacific is a lucrative market backed by countries such as India, China, and Japan. Increasing interest of top players in this region due to improving economic conditions and developing healthcare infrastructure are the major drivers of the DNA polymerase market
Key benefits of the report:
- This study presents the analytical depiction of the global DNA polymerase industry along with the current trends and future estimations to determine the imminent investment pockets.
- The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the global DNA polymerase market share.
- The current market is quantitatively analyzed to highlight the global DNA polymerase market growth scenario.
- Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market.
- The report provides a detailed global DNA polymerase market analysis based on competitive intensity and how the competition will take shape in coming years.
Questions answered in the DNA polymerase Market research report:
- What are the leading market players active in the DNA polymerase market?
- What the current trends will influence the market in the next few years?
- What are the driving factors, restraints, and opportunities in the market?
- What are the projections for the future that would help in taking further strategic steps?
Dna Polymerase Market Report Highlights
By End Users
Key Market Players
Excell Bio, SYGNIS AG, Thermo Fisher Scientific, Hoffmann-la Roche, New England Biolabs, Novus Biologicals, Merck KGaA, Agilent Technologies, Illumina Inc., Qiagen